Fictional superheroes are often charged with the task of saving the world from villains such as the Joker, Lex Luthor, Doctor Doom, and the Green Goblin. But superheroes cannot be effective if they only take out one of their villains and let the others roam free. In the same way, the pharmaceutical industry cannot effectively tackle the issue of delays in the execution of clinical trial agreements (CTAs) that leave patients lives hanging in the balance by only addressing one or two of the villains contributing to this broad ...
Read More
Fictional superheroes are often charged with the task of saving the world from villains such as the Joker, Lex Luthor, Doctor Doom, and the Green Goblin. But superheroes cannot be effective if they only take out one of their villains and let the others roam free. In the same way, the pharmaceutical industry cannot effectively tackle the issue of delays in the execution of clinical trial agreements (CTAs) that leave patients lives hanging in the balance by only addressing one or two of the villains contributing to this broad challenge. Dbora Araujo relies on seasoned experience in the pharmaceutical industry that includes consulting for Fortune 500 companies and driving practical change regarding the business aspects of clinical trials to share a comprehensive exploration of the four villains who contribute to CTA negotiation delays and provide practical ways to address each of them. While encouraging positive change that patients desperately need, Araujo examines the negative impacts of ineffective site-budget negotiations, poor outsourced negotiations, a lack of industry adoption and innovation, and other issues affecting CTA negotiations. Included are several checklists, a common language evaluation and reconciliation initiative, and general CTA country requirements. In this comprehensive study, a pharmaceutical professional creatively examines how to address the four villains that cause frustrating delays in the execution of clinical trial agreements.
Read Less
Add this copy of The Four Villains of Clinical Trial Agreement Delays to cart. $7.99, good condition, Sold by Russell Books rated 4.0 out of 5 stars, ships from Victoria, BC, CANADA, published 2018 by WestBow Press.
Add this copy of The Four Villains of Clinical Trial Agreement Delays to cart. $8.96, fair condition, Sold by Goodwill Industries rated 5.0 out of 5 stars, ships from Miami, FL, UNITED STATES, published 2018 by WestBowPress.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Fair. Books may have damage such as dents creases and folded pages. Some books may have writing or highlighting inside. Extras or accessories are not guaranteed. Digital codes and CDs are not tested and may not work.
Add this copy of The Four Villains of Clinical Trial Agreement Delays to cart. $9.09, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2018 by WestBow Press.
Add this copy of The Four Villains of Clinical Trial Agreement Delays to cart. $26.96, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2018 by WestBowPress.
Add this copy of The Four Villains of Clinical Trial Agreement Delays to cart. $55.68, new condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2018 by WestBowPress.
